Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 20, 2007
- FPMAJ Calls For 3-Level Premiums for Innovativeness
August 20, 2007
- SELF-MEDICATION NEWS IN BRIEF
August 20, 2007
- Fixed-Point ADR Observation Project to Be Expanded: New SD Director
August 20, 2007
- Bayer Yakuhin to Focus on Specialty Drugs
August 20, 2007
- Summary of FPMAJ's Opinions on NHI Drug Pricing System
August 20, 2007
- Bayer Launches l'strogel without NHI Price Listing
August 20, 2007
- Number of Essential GCP Documents to Be Halved
August 20, 2007
- Takeda to License CCR5 Antagonists to Tobira Therapeutics
August 20, 2007
- Takeda, Santhera Extend Marketing Collaboration in EU for SNT-MC17
August 20, 2007
- Astellas Reorganizes European Business Functions
August 20, 2007
- REGULATORY NEWS IN BRIEF(1)
August 20, 2007
- Chugai: Half-Year Sales Up 12%, Ordinary Profits Up 30.5%
August 20, 2007
- REGULATORY NEWS IN BRIEF(2)
August 20, 2007
- Takeda, Taiyo in Dispute over Recall of Pansporin
August 20, 2007
- Nippon Shinyaku to Create "Monitor System" to Have New Compounds Assessed by Outside Experts
August 20, 2007
- BUSINESS NEWS IN BRIEF
August 20, 2007
- WC6 on Alternatives and Animal Use in Life Sciences to Be Held in Tokyo
August 20, 2007
- TOPICS／ACTOS Offers Safety Profile: Takeda
August 20, 2007
- R&D NEWS IN BRIEF
August 20, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…